Research Department of Pharmaceutics, School of Pharmacy, University College London, London, UK.
Future Microbiol. 2019 Mar;14:263-265. doi: 10.2217/fmb-2019-0016. Epub 2019 Feb 13.
In this exclusive interview, Simon Gaisford discusses his current research into gut dysbiosis and its possible relevance to disease states, as well as the efficacy of probiotic supplementation and its possible use as treatment. This interview was conducted by Ellen Colvin, Commissioning Editor of Future Microbiology. Professor Simon Gaisford is the Head of Department at UCL School of Pharmacy, University College London. He uses isothermal microcalorimetry to monitor the growth and interactions of bacteria, with his research-interest focus on the use of probiotic supplements to improve general health and well-being, ameliorate symptoms of disease and eradicate gut pathogens. He has published 120 papers, four books and eight book chapters.
在本次专访中，西蒙·盖斯福德教授探讨了其目前关于肠道菌群失调及其与疾病状态相关性的研究，以及益生菌补充剂的功效及其作为治疗手段的可能用途。本次采访由《未来微生物学》的特约编辑艾伦·科尔文（Ellen Colvin）进行。西蒙·盖斯福德教授是伦敦大学学院药学院的系主任。他使用等温微量热法来监测细菌的生长和相互作用，他的研究兴趣集中在使用益生菌补充剂来改善整体健康和幸福感、减轻疾病症状和消除肠道病原体上。他已经发表了 120 篇论文、四本书和八章书的内容。
